Stock Track | LAEKNA-B Soars 7.43% Amid Biotech Stock Rally in Hong Kong

Stock Track

2025/08/19

LAEKNA-B (02105), also known as LaiKang Medicine, saw its stock price soar by 7.43% during early trading on Tuesday, outperforming the broader biotech sector in Hong Kong. The significant uptick comes as part of a wider rally in Hong Kong's biotech stocks, indicating strong investor confidence in the sector.

The biotech sector in Hong Kong demonstrated notable activity, with several companies posting gains. Transcenta led the pack with a 9% increase, while other firms such as Venus Medtech, Kelun-Biotech Biopharmaceutical, and Luzhu Biotechnology also recorded positive movements ranging from 2% to 4%.

While no company-specific news for LAEKNA-B was reported, the overall positive sentiment in the biotech sector appears to have boosted investor interest in the stock. This surge underscores the current market optimism surrounding biotech firms in Hong Kong and may reflect broader positive trends in the healthcare and pharmaceutical industries.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1163077419"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1163077419\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1163077419?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-19 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163077419","market":"nz","top_or_hot":-1,"title":"Stock Track | LAEKNA-B Soars 7.43% Amid Biotech Stock Rally in Hong Kong","media":"Stock Track","content":"<p>LAEKNA-B (02105), also known as LaiKang Medicine, saw its stock price soar by 7.43% during early trading on Tuesday, outperforming the broader biotech sector in Hong Kong. The significant uptick comes as part of a wider rally in Hong Kong's biotech stocks, indicating strong investor confidence in the sector.</p>\n\n<p>The biotech sector in Hong Kong demonstrated notable activity, with several companies posting gains. Transcenta led the pack with a 9% increase, while other firms such as Venus Medtech, Kelun-Biotech Biopharmaceutical, and Luzhu Biotechnology also recorded positive movements ranging from 2% to 4%.</p>\n\n<p>While no company-specific news for LAEKNA-B was reported, the overall positive sentiment in the biotech sector appears to have boosted investor interest in the stock. This surge underscores the current market optimism surrounding biotech firms in Hong Kong and may reflect broader positive trends in the healthcare and pharmaceutical industries.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | LAEKNA-B Soars 7.43% Amid Biotech Stock Rally in Hong Kong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | LAEKNA-B Soars 7.43% Amid Biotech Stock Rally in Hong Kong\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-19 10:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LAEKNA-B (02105), also known as LaiKang Medicine, saw its stock price soar by 7.43% during early trading on Tuesday, outperforming the broader biotech sector in Hong Kong. The significant uptick comes as part of a wider rally in Hong Kong's biotech stocks, indicating strong investor confidence in the sector.</p>\n\n<p>The biotech sector in Hong Kong demonstrated notable activity, with several companies posting gains. Transcenta led the pack with a 9% increase, while other firms such as Venus Medtech, Kelun-Biotech Biopharmaceutical, and Luzhu Biotechnology also recorded positive movements ranging from 2% to 4%.</p>\n\n<p>While no company-specific news for LAEKNA-B was reported, the overall positive sentiment in the biotech sector appears to have boosted investor interest in the stock. This surge underscores the current market optimism surrounding biotech firms in Hong Kong and may reflect broader positive trends in the healthcare and pharmaceutical industries.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02105","symbol_name":"来凯医药-B","start_time":0,"source_url":"","article_id":"1163077419","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163077419","pubTimestamp":1755568962,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"LAEKNA-B (02105), also known as LaiKang Medicine, saw its stock price soar by 7.43% during early trading on Tuesday, outperforming the broader biotech sector in Hong Kong. The significant uptick...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02105":"来凯医药-B"},"translate_title":"个股追踪|港股生物科技股大涨LAEKNA-B大涨7.43%","themeId":"3c69330474cfca501aba698b1d21b7cf","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02105":1},"content_text":"LAEKNA-B (02105), also known as LaiKang Medicine, saw its stock price soar by 7.43% during early trading on Tuesday, outperforming the broader biotech sector in Hong Kong. The significant uptick comes as part of a wider rally in Hong Kong's biotech stocks, indicating strong investor confidence in the sector.\nThe biotech sector in Hong Kong demonstrated notable activity, with several companies posting gains. Transcenta led the pack with a 9% increase, while other firms such as Venus Medtech, Kelun-Biotech Biopharmaceutical, and Luzhu Biotechnology also recorded positive movements ranging from 2% to 4%.\nWhile no company-specific news for LAEKNA-B was reported, the overall positive sentiment in the biotech sector appears to have boosted investor interest in the stock. This surge underscores the current market optimism surrounding biotech firms in Hong Kong and may reflect broader positive trends in the healthcare and pharmaceutical industries.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}